BeStock  
Markets › Compare › ALPMY vs MTCPY

ALPMY vs MTCPY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ALPMY · Astellas Pharma (ADR)$17.20 ▲ 0.29%
MTCPY · MTR CORP$11.31 ▲ 0.00%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

87100113126139Nov 24, '25May 26, '26Nov 20, '26
  • ALPMY +36.5%
  • MTCPY +2.5%

Head to head

MetricALPMYMTCPY
Price$17.20$11.31
Change today▲ 0.29%▲ 0.00%
Market cap$25.68B$25.67B
Return, 3 months+14.4%+1.5%
Return, year to date+29.4%+2.1%
Return, 1 year+36.9%+2.5%
P/E (TTM)12.68.0
P/B2.50.9
P/E percentile vs own 5y––
Dividend yield1.42%4.42%
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)7217
30-day volatility24.2%32.4%
Max drawdown, 1 year-22.3%-19.4%
Trend readStrong uptrendStrong downtrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ALPMY is the largest of the group by market value.
  • ALPMY has returned the most over the past year.
  • MTCPY carries the lowest trailing P/E.
  • MTCPY pays the highest dividend yield.
  • ALPMY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top